AVADEL PHARMACEUTICALS PLC
Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.
AVDL | US
Overview
Corporate Details
- ISIN(s):
- IE00BDGMC594
- LEI:
- Country:
- United States of America
- Address:
- 10 EARLSFORT TERRACE, DUBLIN 2
- Website:
- https://www.avadel.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Avadel Pharmaceuticals PLC is a biopharmaceutical company focused on developing and commercializing therapies that address unmet medical needs, particularly in the area of sleep disorders. The company's primary focus is on narcolepsy, a chronic neurological condition. Its lead commercial product is LUMRYZ™, an extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Avadel's strategy involves applying innovative drug delivery technologies to improve upon existing treatment paradigms, with LUMRYZ designed as a once-at-bedtime therapy to eliminate the need for middle-of-the-night dosing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AVADEL PHARMACEUTICALS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AVADEL PHARMACEUTICALS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AVADEL PHARMACEUTICALS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
